first-IN-class MEDICATIONs to treat psychostimulant addictions
Through working partnerships with academic institutions, private companies, foundations, and publicly funded government agencies, we create an accelerated pipeline for promising new therapeutics that will fuel the transformation of mental health care.
focus on early r&D to create accelerated pathways to fda approval
Our company brings together top researchers and practitioners in the fields of psychiatry, neurology, neuropathology, and neuropharmacology for the efficient development of treatment options to prevent, treat, and cure neurological diseases.
to Heal the Mind
2015 Neuro startup challenge finalists